Observational Study of Oral Atogepant to Evaluate Real-World Effectiveness in Adult Participants With Migraine (NCT06543914)
A ProspeCtive ObseRvatioNal Study of Atogepant Effectiveness in Routine Clinical Practice
🩺 Plain-English Summary (8th-Grade Level)
Migraine is a neurological disease characterized by moderate or severe headache, associated with nausea, vomiting, and/or sensitivity to light and sound. This study will evaluate the effectiveness of atogepant in treating adult participants with migraine in a real-world setting. Atogepant is an approved drug for preventive treatment of migraine in adults. Approximately 1000 adult participants who are prescribed atogepant by their doctors will be enrolled in this study across the world. Participants will receive atogepant oral tablets as prescribed per standard clinical practice and will be followed for 2 years. There is expected to be no additional burden for participants in this trial. Participants will attend regular visits during the study at a hospital or clinic according to their routine clinical practice.
Who can join: Review the eligibility criteria below.
Location: Neurology and Neurodiagnostics of Alabama /ID# 267614 — Hoover, Alabama
Age range: 18 Years
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (112 Sites)
Showing the first 25 of 112 sites.
- Neurology and Neurodiagnostics of Alabama /ID# 267614 — Hoover, Alabama
- Rehabilitation & Neurological Services /ID# 267612 — Huntsville, Alabama
- Barrow Neurological Institute - Dignity Health St. Joseph's Hosp and Medical Ctr /ID# 267610 — Phoenix, Arizona
- Kenneth Martinez MD, A Medical Corp /ID# 267834 — Aliso Viejo, California
- BNL Health - Los Angeles Headache Center /ID# 267570 — Los Angeles, California
- Alcanza Clinical Research, LLC /ID# 267838 — Lake Mary, Florida
- Norton Cancer Institute - St. Matthews /ID# 267605 — Louisville, Kentucky
- Dent Neurologic Institute - Amherst /ID# 267606 — Amherst, New York
- Northwell Health - Great Neck /ID# 280705 — Great Neck, New York
- Northwell Health /ID# 267596 — New York, New York
- Thomas Jefferson University Hospital /ID# 267572 — Philadelphia, Pennsylvania
- Inova Health Care System /ID# 267615 — Falls Church, Virginia
- Neuroscience Group /ID# 267571 — Neenah, Wisconsin
- Cliniques Universitaires UCL Saint-Luc /ID# 270545 — Brussels, Brussels Capital
- Universitair Ziekenhuis Brussel /ID# 269799 — Jette, Brussels Capital
- Chu Tivoli /ID# 271254 — La Louvière, Hainaut
- Centre Hospitalier Régional de la Citadelle /ID# 270539 — Liège, Liege
- Groupe Sante CHC - Clinique du MontLegia /ID# 270218 — Liège, Liege
- OLV Ziekenhuis Aalst /ID# 270284 — Aalst, Oost-Vlaanderen
- Algemeen Ziekenhuis Sint-Jan Brugge /ID# 270540 — Bruges, West-Vlaanderen
- AZ Groeninge /ID# 272772 — Kortrijk, West-Vlaanderen
- Calgary Headache Assessment and Management Program /ID# 270266 — Calgary, Alberta
- Burrard Health Center /ID# 270268 — Vancouver, British Columbia
- Dr. Renju Kuriakose Prof. Corp. /ID# 273178 — Saint John, New Brunswick
- Maritime Neurology /ID# 270270 — Halifax, Nova Scotia
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Migraine
- A Study of Wearable Devices to Predict Migraines — Rochester, Minnesota
- Treatment for Migraine and Mood — The Bronx, New York
- Study of Oral Ubrogepant to Assess Adverse Events and Change in Disease Activity in Adult Participants With Menstrual Migraine — Birmingham, Alabama
- A Study to Evaluate White Matter Hyperintensities in Migraine — Phoenix, Arizona
- Migraine Manager (R01) — Cincinnati, Ohio
- Nerivio Efficacy Under High-Frequency Use — Bridgewater, New Jersey
Explore by condition: All Migraine clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Review the official NIH record below to find the coordinating site.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.